Source comparison
BPC-157 for Post-Workout Recovery: Comparison Table
Before selecting a recovery protocol, here's how BPC-157 stacks up against other commonly used regenerative approaches: BPC-157 VEGF stabilisation, angiogenesis, collagen upregulation 200–500 mcg/day subcutaneous Preclinical models, limited human trials 40–60%
This comparison does not assign a generated winner or score.
- Before selecting a recovery protocol, here's how BPC-157 stacks up against other commonly used regenerative approaches:
- BPC-157
- VEGF stabilisation, angiogenesis, collagen upregulation
- 200–500 mcg/day subcutaneous
- Preclinical models, limited human trials
- 40–60% faster healing in tendon/ligament injuries
- Most mechanistically robust regenerative peptide for soft tissue. Efficacy limited by injection compliance
- TB-500 (Thymosin Beta-4)
- Actin upregulation, cell migration, anti-inflammatory
- 2–5 mg twice weekly subcutaneous
- Preclinical and equine models
- 30–50% faster healing in muscle injuries
- Complementary to BPC-157. Works through different pathway (cytoskeletal vs vascular)
- Hyperbaric Oxygen Therapy (HBOT)
- Increased dissolved oxygen in plasma, angiogenesis
- 60–90 min at 2.0–2.5 ATA daily
- Meta-analyses of RCTs
- 20–40% faster wound healing
- Proven efficacy but logistically intensive. Best for acute injuries, not daily post-workout recovery
- Cryotherapy
- Vasoconstriction, reduced metabolic demand
- 2–4 min at −110°C post-training
- Mixed. Some RCTs show no benefit
- Subjective soreness reduction, no structural healing effect
- Reduces perceived soreness but may blunt hypertrophy signalling. Timing matters
- NSAID Use (Ibuprofen)
- COX enzyme inhibition, prostaglandin suppression
- 400–800 mg post-training
- Well-established mechanism
- Delays healing by 25–50% in some models
- Actively counterproductive for recovery. Suppresses inflammation required for adaptation